More by Author

NIH seeks the next generation of COVID-19 diagnostics

NIH has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 diagnostics.

Two Monumental Milestones Achieved in CT Imaging

One team helped develop the first photon-counting detector (PCD)-CT system, which is superior to current CT technology. Another team has also been using artificial intelligence to lower the dose of radiation given to a patient when they are undergoing a conventional CT brain scan.

RADx initiative issues contracts for new COVID-19 tests to fill gaps

RADx Tech program has issued contracts to help meet the ongoing needs and challenges of COVID-19 diagnostic testing.

NIH RADx Tech to tackle development of at-home COVID-19 tests with improved accessibility for users

The National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx®) Tech program is working to identify necessary elements of at-home COVID-19 diagnostic test kits that may be used independently by people with disabilities.

RADx expands COVID-19 home and point-of-care testing, wastewater surveillance

The National Institutes of Health (NIH) today announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel COVID-19 testing technologies.

RADx diversifies COVID-19 test portfolio with four new contracts, including one to detect variants

NIH has awarded four additional contracts for the development and scaled-up manufacturing of new COVID-19 diagnostic testing technologies through its Rapid Acceleration of Diagnostics Tech (RADx) initiative. The awards total $29.3 million and will help increase testing capacity for COVID-19.

NIH’s RADx Tech program inks additional contracts for COVID-19 diagnostic tests and supplies

The National Institutes of Health has awarded three new contracts totaling $36.7 million for the development of new COVID-19 diagnostic testing technologies and production of specimen collection kits and swabs. The Rapid Acceleration of Diagnostics (RADx) initiative has advanced the scale-up of 25 testing projects since July 2020, which now include lab-based, point-of-care, and potential at-home formats.

In Memoriam: Sanjiv “Sam” Gambhir, M.D., Ph.D.

NIBIB mourns the passing of molecular imaging pioneer and NIBIB Advisory Council member, Sanjiv “Sam” Gambhir, M.D., Ph.D.

Nerve stimulation helps manage pain without opioids

Researchers at the University of Wisconsin (UW) are adapting a minimally invasive, safer approach to electrically treat pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.

Disarming bacteria with mucus and phages

Millions of people are treated with antibiotics each year for infections or as a preventative measure. Two teams of NIBIB-funded scientists have been working to find alternative solutions for treating bacterial infections, especially antibiotic-resistant bacteria.

Radiotracers are revolutionized with a novel method

A novel method produces a new class of radioactive tracers that are used for medical imaging. The method allows them to attach radioactive atoms to compounds that have previously been difficult or even impossible to label. The advance will make it easier to track medications in the body and identify tumors and other diseases.